 Global biotech unlocking the potential of personalized therapies and closed processing systems helpful in manufacturing Maryland-based firm has a Cell and Gene Therapy CGT Biotech platform The platform consists of three core elements: POCare Therapeutics, POCare Technologies, and POCare Network What Orgenesis NASDAQ:ORGS does: OrGenesis TSX:GDC Inc. is focused on unlocking the potential of personalized therapies and closed processing systems through its cell and gene therapy platform. Cell and gene therapies CGTs use modified cells or cellular matter to treat, prevent or cure serious health issues. 